CHEBI:18217 - α-D-Gal-(1→3)-β-D-Gal-(1→4)-D-GlcNAc

Main ChEBI Ontology Automatic Xrefs Reactions Pathways Models
ChEBI Name α-D-Gal-(1→3)-β-D-Gal-(1→4)-D-GlcNAc
ChEBI ID CHEBI:18217
ChEBI ASCII Name alpha-D-Gal-(1->3)-beta-D-Gal-(1->4)-D-GlcNAc
Definition An amino trisaccharide consisting of two D-galactose residues, linked α(1→3), and an N-acetyl-D-glucosamine residue, linked β(1→4), at the reducing end.
Stars This entity has been manually annotated by the ChEBI Team.
Secondary ChEBI IDs CHEBI:60182, CHEBI:22379, CHEBI:10236, CHEBI:12311
Supplier Information
Download Molfile XML SDF
more structures >>
Formulae C20H35NO16
C20H35NO16
Net Charge 0
Average Mass 545.48900
Monoisotopic Mass 545.19558
InChI InChI=1S/C20H35NO16/c1-5(25)21-9-12(28)16(8(4-24)33-18(9)32)36-20-15(31)17(11(27)7(3-23)35-20)37-19-14(30)13(29)10(26)6(2-22)34-19/h6-20,22-24,26-32H,2-4H2,1H3,(H,21,25)/t6-,7-,8-,9-,10+,11+,12-,13+,14-,15-,16-,17+,18?,19-,20+/m1/s1
InChIKey NNISLDGFPWIBDF-MPRBLYSKSA-N
SMILES CC(=O)N[C@H]1C(O)O[C@H](CO)[C@@H](O[C@@H]2O[C@H](CO)[C@H](O)[C@H](O[C@H]3O[C@H](CO)[C@H](O)[C@H](O)[C@H]3O)[C@H]2O)[C@@H]1O
Roles Classification
Biological Role(s): allergen
A chemical compound, or part thereof, which causes the onset of an allergic reaction by interacting with any of the molecular pathways involved in an allergy.
View more via ChEBI Ontology
ChEBI Ontology
Outgoing α-D-Gal-(1→3)-β-D-Gal-(1→4)-D-GlcNAc (CHEBI:18217) has role allergen (CHEBI:50904)
α-D-Gal-(1→3)-β-D-Gal-(1→4)-D-GlcNAc (CHEBI:18217) is a amino trisaccharide (CHEBI:59266)
α-D-Gal-(1→3)-β-D-Gal-(1→4)-D-GlcNAc (CHEBI:18217) is a glucosamine oligosaccharide (CHEBI:22485)
Incoming α-D-Galp-(1→3)-β-D-Galp-(1→4)-β-D-GlcpNAc (CHEBI:62327) is a α-D-Gal-(1→3)-β-D-Gal-(1→4)-D-GlcNAc (CHEBI:18217)
α-D-Galp-(1→3)-β-D-Galp-(1→4)-D-GlcpNAc-yl group (CHEBI:17785) is substituent group from α-D-Gal-(1→3)-β-D-Gal-(1→4)-D-GlcNAc (CHEBI:18217)
IUPAC Name
α-D-galactopyranosyl-(1→3)-β-D-galactopyranosyl-(1→4)-2-acetamido-2-deoxy-D-glucopyranose
Synonyms Sources
(Gal)2 (GlcNAc)1 KEGG GLYCAN
α-D-galactosyl-1,3-β-D-galactosyl-1,4-N-acetyl-D-glucosamine UniProt
alpha-D-Galactosyl-1,3-beta-D-galactosyl-1,4-N-acetyl-D-glucosamine KEGG COMPOUND
α-D-Galp-(1→3)-β-D-Galp-(1→4)-D-GlcNAc JCBN
α-D-Galp-(1→3)-β-D-Galp-(1→4)-D-GlcpNAc ChEBI
α-gal ChEBI
α-gal trisaccharide ChEBI
αGal1-3βGal1-4GlcNAc ChEBI
gal-α-1,3-gal-β-1,4-GlcNAc ChEBI
Galα1-3Galβ1-4GlcNAc ChEBI
WURCS=2.0/3,3,2/[a2122h-1x_1-5_2*NCC/3=O][a2112h-1b_1-5][a2112h-1a_1-5]/1-2-3/a4-b1_b3-c1 GlyTouCan
Manual Xrefs Databases
C04847 KEGG COMPOUND
G00304 KEGG GLYCAN
G27798EJ GlyTouCan
G27798EJ GlyGen
View more database links
Registry Numbers Types Sources
5322979 Beilstein Registry Number Beilstein
5322979 Reaxys Registry Number Reaxys
Citations Waiting for Citations Types Sources
10096519 PubMed citation Europe PMC
10355731 PubMed citation Europe PMC
11549456 PubMed citation Europe PMC
12009948 PubMed citation Europe PMC
12544864 PubMed citation Europe PMC
16442513 PubMed citation Europe PMC
17991151 PubMed citation Europe PMC
19913595 PubMed citation Europe PMC
27261450 PubMed citation Europe PMC
28472163 PubMed citation Europe PMC
9741457 PubMed citation Europe PMC
Last Modified
07 April 2021